| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917849 | Radiotherapy and Oncology | 2016 | 5 Pages |
Abstract
Our clinical and dosimetric data suggest that the noted dose constraints are safe and acceptable with regard to spinal cord complications. Pre-existing disease characteristics, surgical complications, as well as tumor progression, appear to be more important factors when it comes to spinal cord toxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Varun K. Chowdhry, Li Liu, Saveli Goldberg, Judith A. Adams, Karen De Amorim Bernstein, Norbert J. Liebsch, Andrzej Niemierko, Yen-Lin Chen, Thomas F. DeLaney,